Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000428508 | SCV000517526 | benign | not specified | 2016-01-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001515225 | SCV001723246 | benign | Combined oxidative phosphorylation defect type 27 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000428508 | SCV005091636 | benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 49% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 46. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV004707227 | SCV005229860 | benign | not provided | criteria provided, single submitter | not provided |